Pressure Biosciences, Inc. (PBIO.OB) Quarter Highlights, Outlook and Sources of Income
A number of analysts have issued a strong buy on Pressure Bio-Sciences citing that investors will soon realize the value of the company’s technologies. They have set 12-month price targets significantly higher than the current trading price offering investors the opportunity to profit from this company’s innovative products that could revolutionize the medical world, where it has been well received already. With its Sales force now in position, they are poised to ramp up demand for their technologies. The company’s main product is its line of Barocycler Instruments. They also receive generous revenue streams from the accompanying Pulse Tubes and…